About P&T JournalContacts:
Statement of Purpose
Guidelines for Authors
Pushing an Expanded Role for Pharmacists: Medicare, SCHIP, and Health Insurance Debates Present Ample Opportunities
With a new administration in place, pharmacists may play a larger advisory role.
Better Asthma Management with Advanced Technology: Creation of an Asthma Utilization Rx Analyzer (AURA) Tool
The AURA tool enables health plans to evaluate quality and use of resources for their members with asthma by analyzing medical and pharmacy claims.
James H. Jackson, PharmD, MPH; Benjamin Gutierrez, PhD; Orsolya E. Lunacsek, PhD, MBA; and Sulabha Ramachandran, PhD
Products include fospropofol for sedation; plerixafor to prepare patients for transplantation; and fenofibric acid for improving triglycerides and cholesterol.
Marvin M. Goldenberg, PhD, RPh, MS
The authors report on a project to sequence the genomes of more than 1,000 people; Gaucher’s disease; warfarin genetics; and Huntington’s disease.
Safiya Abouzaid, PharmD; Joseph E. Couto, PharmD, MBA; and Marc B. Royo
Topics include leukemias, myelodysplastic disorder, multiple myeloma, paroxysmal nocturnal hemoglobinuria, and idiopathic thrombocytopenic purpura.
Summaries discuss zoledronic acid, everolimus, lapatinib, and letrozole.
Third edition of a classic psychopharmacology text
Reviewed by David A. Casey, MD
David B. Nash, MD, MBA, describes the goals of the National Quality Forum in improving health care in six key areas as well as eliminating unnecessary services.
David B. Nash, MD, MBA
Matthew Grissinger, RPh, FASCP, explains how patients can be harmed when glacial (pure) acetic acid, instead of a diluted form, is dispensed.
Matthew Grissinger, RPh, FASCP
Stephen Barlas discusses the long-simmering debate over the content of consumer medication information.
From Mozobil to Zolpimist, P&T presents the latest studies and information about FDA approvals, new indications, recalls, and industry updates.
Hoyee Leong, PhD, and Mary Ellen Bonk, PharmD, review bendamustine (Treanda), a therapy for chronic lymphocytic leukemia.
Hoyee Leong, PhD, and Mary Ellen Bonk, PharmD